What is the main business of Clinical Trials Solutions?

The main business activity of Clinical Trials Solutions focuses on other data processing, hosting and related activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 30, 2018.

Where is the headquarters located?

The headquarters is located at: Złota 75A, 00-819 Warszawa.

What is the share capital?

The share capital of the company is PLN 34,650 (approx. $9,360).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of $163,097 in 2025, which is a decrease of 71.9% compared to 2024.

No, the company recorded a net loss of $351,987 in 2025.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $158,002 in 2025, representing 35% of all operating expenses.

Clinical Trials Solutionssp. z o.o.

Other data processing, hosting and related activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-01-30

Share capital

34 650,00 PLN

Activity description

Clinical Trials Solutions is a provider of the SMARTrials® platform, an integrated Clinical Trials Management Platform (CTMP) that supports research teams in managing clinical trials effectively. The platform consolidates key processes for planning, monitoring, evaluating, and improving both business efficiency and the quality of clinical research. It offers tools designed to enhance recruitment strategies and patient retention for clinical research centers and organizations managing studies.

Registered address

Złota 75A/7, 00-819 Warszawa, Poland

Website

ctsolutions.eu

Phone

Electronic delivery address

AE:PL-54525-89002-GFRSV-17

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 163.10kMedianUSD 150.48kAverageUSD 5.32m

Net profit

This companyUSD -351.99kMedianUSD 3.26kAverageUSD 584.89k

Operating costs

This companyUSD 451.12kMedianUSD 106.32kAverageUSD 4.44m

Assets

This companyUSD 2.43mMedianUSD 112.24kAverageUSD 5.55m

Industry

Bank accounts

Registered as a VAT taxpayer on 2018-03-01. Active

ING Bank Śląski
78 1050 1722 1000 0090 8033 9550

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

Type	Amount
Buildings and premises	PLN 4,946PLN 4,946

Public aid

7 public aid cases recorded, with a total value of $146,030.

Grant date	Purpose	Gross amount	Granting body
Jun 27, 2022	Other crisis aid	$16,601$16,601	Tarnowska Agencja Rozwoju Regionalnego S.A.
Jun 27, 2022	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,971$3,971	Tarnowska Agencja Rozwoju Regionalnego S.A.
Sep 21, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$115.4K$115,391	Tarnowska Agencja Rozwoju Regionalnego S.A.

Tenders

3 tenders recorded as contractor: 2 national ($336,574) and 1 EU ($148,035).

Publication date	Subject	Amount	Contracting authority
Jul 21, 2026	„Zakup systemów teleinformatycznych, jakościowych i innych wspierających zarządzanie Badaniami klinicznymi w tym: System do zarządzania badaniami klinicznymi oraz System do realizacji studium wykonalności (ang. feasibility)” w ramach projektu „Centrum Wsparcia Badań Klinicznych dla Mazowsza Zachodniego”.	$148.0K$148,035	Mazowieckie Centrum Leczenia Chorób Płuc I Gruźlicy
Apr 17, 2026	Zakup i wdrożenie zintegrowanego systemu informatycznego do zarządzania badaniami klinicznymi w ramach projektu "Centrum Wsparcia Badań Klinicznych dla Mazowsza Zachodniego"	$182.6K$182,604	Centrum Zdrowia Mazowsza Zachodniego sp. z o.o.
Apr 18, 2023	ZP/2/2023 - Usługa zaprojektowania, wdrożenia, świadczenia serwisu gwarancyjnego i nadzoru oraz wsparcia systemu informatycznego dla Onkologicznego Centrum Wsparcia Badań Klinicznych Instytutu „CZMP”	$154.0K$153,971	Instytut Centrum Zdrowia Matki Polki

Public sector contracts

Clinical Trials Solutions is the contractor in one public sector contract, worth PLN 85.20k.

Signed	Subject	Public buyer	Value
Sep 2, 2026	Platforma Edukacyjno-Konsultacyjna	Uniwersytet Medyczny w Lublinie	PLN 85,200

Public buyer	Value
Uniwersytet Medyczny w Lublinie	PLN 85,200

Public procurement disputes (KIO)

Clinical Trials Solutions has been a party to 4 cases before the National Appeal Chamber (since 2022). It filed 3 appeals (3 discontinued). In 1 case it joined the proceedings as a participant.

Date	Case no.	Role	Other party	Outcome
Dec 8, 2025	KIO 4713/25	Appellant	Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy w Warszawie	Discontinued
Mar 6, 2023	KIO 448/23	Participant (on authority's side)	Instytut "Centrum Zdrowia Matki Polki"	Upheld
Feb 24, 2023	KIO 421/23	Appellant	Świętokrzyskie Centrum Onkologii w Kielcach	Discontinued
Jun 23, 2022	KIO 1521/22	Appellant	Uniwersytet Medyczny w Łodzi, Samodzielny Publiczny Zakład Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodzi, Samodzielny Publiczny Zakład Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej Uniwersytetu Medycznego w Łodzi - Centralnym Szpitalem Weteranów oraz Samodzielny Publiczny Zakład Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Łodzi	Discontinued

Trademarks

Clinical Trials Solutions holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2018.

Mark	Number	Classes	Status	Protected until
SMARTrials(word)	Z.483426	9	Protected	Mar 13, 2028
SMARTrials	Z.483427	9	Protected	Mar 13, 2028

Mark	Protected until
SMARTrials(word)	Mar 13, 2028
SMARTrials	Mar 13, 2028

Authorized Representatives

Marek Konieczny – President of the Management Board

Manner of representation

In the case of a one-person management board, the President of the Management Board acts independently. In the case of a multi-member management board, the company shall be represented by the President of the Management Board acting independently, or by two members of the management board acting jointly.

Ownership

Owner	Shares	Share value	Stake
Arbet Park sp. z o.o.	231	$3,119.94	33.3333%
Marek Konieczny (56)	231	$3,119.94	33.3333%
Stanisław Pisarski (66)	231	$3,119.94	33.3333%

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
Turbo TradeS.A.	$253,102.31	turbotrade.pl
Chory.Plsp. z o.o.	$241,401.58	chory.pl
Multisourcesp. z o.o.	$177,399.15	multi-source.pl
ImpleP.S.A.	$31,810.70	imple.pl

Change history

Date	Event
2025-07-10	Share capital change (24,250.00 PLN → 34,650.00 PLN)
2025-05-23	Address change (Pl. Dworcowy 4, 33-100, Tarnów → Złota 75a/7, 00-819, Warszawa)
2025-05-23	Share capital change (23,500.00 PLN → 24,250.00 PLN)
2025-05-23	PKD change (Removed: 46.51.Z, 62.01.Z, 62.02.Z, 62.03.Z, 63.11.Z, 63.12.Z; Added: 46.50.Z, 60.39.Z, 62.10.B, 62.20.A, 62.20.B, 62.90.Z, 63.10.A, 63.10.D, 72.10.Z)
2019-04-16	Share capital change (20,000.00 PLN → 23,500.00 PLN)

FAQ

Last updated: 2026-07-20